Mediolanum International Funds Ltd Has $3.01 Million Stake in HCA Healthcare, Inc. $HCA

Mediolanum International Funds Ltd boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 48.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,151 shares of the company’s stock after acquiring an additional 2,329 shares during the quarter. Mediolanum International Funds Ltd’s holdings in HCA Healthcare were worth $3,010,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Norges Bank acquired a new stake in shares of HCA Healthcare in the second quarter worth about $1,152,408,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after purchasing an additional 896,437 shares during the period. Viking Global Investors LP raised its position in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in HCA Healthcare in the 2nd quarter valued at $109,337,000. Finally, HRT Financial LP acquired a new position in HCA Healthcare during the 2nd quarter worth $81,596,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.6%

HCA stock opened at $496.30 on Tuesday. The company has a market cap of $113.25 billion, a P/E ratio of 17.49, a PEG ratio of 1.50 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $527.55. The business has a fifty day moving average of $480.98 and a 200-day moving average of $439.27.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the previous year, the company earned $6.22 EPS. HCA Healthcare’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is presently 10.15%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on HCA shares. Mizuho set a $540.00 price objective on HCA Healthcare in a research report on Monday. Royal Bank Of Canada increased their price objective on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Bank of America lifted their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Robert W. Baird raised their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $519.71.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.